These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Briejer MR; Akkermans LM; Schuurkes JA Pharmacol Rev; 1995 Dec; 47(4):631-51. PubMed ID: 8746557 [No Abstract] [Full Text] [Related]
3. [Rational conception, synthesis and evaluation of phenytoinergic potential anticonvulsants. A series ofretrobenzamides: N-(nitrophenyl) benzamides and N-(aminophenyl) benzamides]. Bourhim M; Kanyonyo MD; Lambert DM; Poupaert JH; Stables JP; Vamecq J J Pharm Belg; 1997; 52(5):181-9. PubMed ID: 9432526 [TBL] [Abstract][Full Text] [Related]
4. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Pani L; Gessa GL Mol Psychiatry; 2002; 7(3):247-53. PubMed ID: 11920152 [TBL] [Abstract][Full Text] [Related]
5. N-substituted benzamides inhibit NFkappaB activation and induce apoptosis by separate mechanisms. Liberg D; Lazarevic B; Pero RW; Leanderson T Br J Cancer; 1999 Nov; 81(6):981-8. PubMed ID: 10576654 [TBL] [Abstract][Full Text] [Related]
6. Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides. Wolf M; Bauder-Wüst U; Eskerski H; Bauer C; Eisenhut M Melanoma Res; 2007 Apr; 17(2):61-73. PubMed ID: 17496781 [TBL] [Abstract][Full Text] [Related]
7. Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists. Barnett HA; Coe DM; Cooper TW; Jack TI; Jones HT; Macdonald SJ; McLay IM; Rayner N; Sasse RZ; Shipley TJ; Skone PA; Somers GI; Taylor S; Uings IJ; Woolven JM; Weingarten GG Bioorg Med Chem Lett; 2009 Jan; 19(1):158-62. PubMed ID: 19019676 [TBL] [Abstract][Full Text] [Related]
9. [Toxicological characteristic of neuroleptics--substituted benzamides]. Kalekin RA; Salomatin EM; Kalekina VA Sud Med Ekspert; 2007; 50(6):31-4. PubMed ID: 18159758 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase. Asano T; Yoshikawa T; Nakamura H; Uehara Y; Yamamoto Y Bioorg Med Chem Lett; 2004 May; 14(9):2299-302. PubMed ID: 15081028 [TBL] [Abstract][Full Text] [Related]
11. CB2 selective sulfamoyl benzamides: optimization of the amide functionality. Goodman AJ; Ajello CW; Worm K; Le Bourdonnec B; Savolainen MA; O'Hare H; Cassel JA; Stabley GJ; Dehaven RN; Labuda CJ; Koblish M; Little PJ; Brogdon BL; Smith SA; Dolle RE Bioorg Med Chem Lett; 2009 Jan; 19(2):309-13. PubMed ID: 19091565 [TBL] [Abstract][Full Text] [Related]
12. Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides. Anderson AJ; Nicholson JM; Bakare O; Butcher RJ; Wilson TL; Scott KR Bioorg Med Chem; 2006 Feb; 14(4):997-1006. PubMed ID: 16219468 [TBL] [Abstract][Full Text] [Related]
13. 3-(2'-Bromopropionylamino)-benzamides as novel S-phase arrest agents. Hu L; Li ZR; Li JN; Qu J; Jiang JD; Boykin DW Bioorg Med Chem Lett; 2007 Dec; 17(24):6847-52. PubMed ID: 17977727 [TBL] [Abstract][Full Text] [Related]
14. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA. Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimicrobial, and QSAR studies of substituted benzamides. Kumar A; Narasimhan B; Kumar D Bioorg Med Chem; 2007 Jun; 15(12):4113-24. PubMed ID: 17428669 [TBL] [Abstract][Full Text] [Related]
16. Neurobiology of a simple memory. Wilson DA; Linster C J Neurophysiol; 2008 Jul; 100(1):2-7. PubMed ID: 18463176 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases. Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647 [TBL] [Abstract][Full Text] [Related]
20. [The effect of the dispersity of tegalid on its bioavailability]. Lopatina NB; Lebedeva MN; Mikhaĭlitsyn FS; Khalikov SS Med Parazitol (Mosk); 1996; (1):23-5. PubMed ID: 8700005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]